Key Insights

Highlights

Treatment Research

1 treatments under study, led by The Tack Endovascular System

Related Conditions

Often studied with 20 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

50.0%

1 terminated out of 2 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

Trial Status

Terminated1
Recruiting1

Clinical Trials (2)

Research Network

Common Treatments

  • The Tack Endovascular System1

Active Sponsors

  • Spectranetics Corporation1
  • The Cleveland Clinic1

Top Investigators

Related Conditions

  • Nonatherosclerotic Chronic Arterial Occlusive Disease1
  • Fibromuscular Dysplasia1
  • Aneurysmal Disease1
  • Lipedema1
  • Thrombosis1

Activity Timeline